GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients

详细信息	查看全文 | 推荐本文 |

• 作者：Julian Torre-Cisneros^a ; ^{julian.torre.sspa@juntadeandalucia.es} ; M. Carmen Fariñ ; as^b ; Juan José ; Cast&#243 ; n^c ; José ; Marí ; a Aguado^d ; Sara Cantisá ; n^a ; Jordi Carratalá ; ^e ; Carlos Cervera^f ; José ; Miguel Cisneros^g ; Elisa Cordero^g ; Maria G. Crespo-Leiro^h ; Jesú ; s Fortú ; nⁱ ; Esteban Frauca^j ; Joan Gavaldá ; ^k ; Salvador Gil-Vernet^l ; Mercé ; Gurguí ; ^m ; Oscar Len^k ; Carlos Lumbreras^d ; Marí ; a Á ; ngeles Marcosⁿ ; Pilar Martí ; n-Dá ; vilaⁱ ; Victor Monforte^o ; Miguel Montejo^p ; Asunci&#243 ; n Moreno^f ; Patricia Muñ ; oz^q ; David Navarro^r ; Albert Pahissa^k ; José ; Luis Pé ; rez^s ; Alberto Rodriguez-Bernot^t ; José ; Rumbao^u ; Rafael San Juan^d ; Francisco Santos^v ; Evaristo Varo^w ; Felipe Zurbano^x
• 关键词：Cytomegalovirus ; Transplantation ; Prophylaxis ; Pre-emptive therapy ; Treatment ; Consensus
• 刊名：Enfermedades Infecciosas y Microbiolog铆a Cl铆nica
• 出版年：2011
• 期刊代码：pca153_0213005X
• 类别：med
• 出版时间：December 2011
• 卷：29
• 期：10
• 页码：735-758
• 文件大小：374 K

摘要

Cytomegalovirus infection remains a major complication of solid organ transplantation. In 2005 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, numerous publications have clarified or questioned the aspects covered in the previous document. These aspects include the situations and populations who must receive prophylaxis and its duration, the selection of the best diagnosis and monitoring technique and the best therapeutic strategy. For these reasons, we have developed new consensus guidelines to include the latest recommendations on post-transplant CMV management based on new evidence available.